Epigenomic Innovation and Longevity Science in Beauty: L’Oréal and Tru Diagnostic Launch Strategic Partnership

L’Oréal Groupe has announced a strategic research partnership with Tru Diagnostic, a leader in epigenomic testing.

news-main.1744198618.webp

This collaboration explores how epigenetic changes affect beauty, aiming to redefine anti-aging and beauty longevity through science. 

Scientific Synergy for Anti-Aging Breakthroughs 

With over 100 years of expertise in beauty science, L’Oréal and Tru Diagnostic will examine how epigenetic factors impact skin and hair aging. Their research supports the development of anti-aging beauty products that also promote long-term health and vitality. 

Pioneering Longevity Science in Beauty Innovation 

Guive Balooch, Head of Open Innovation at L’Oréal, emphasized the goal of identifying longevity biomarkers. These tools will fuel product development and diagnostic advances, empowering consumers to manage beauty and aging proactively. 

Redefining Beauty Through Epigenetic Science 

Matthew Dawson, CEO of Tru Diagnostic, highlighted epigenomics as a revolution in understanding beauty. This joint effort brings cutting-edge science into the beauty sector to support healthy aging and redefine anti-aging approaches. 

Delivering Holistic and Long-Term Beauty Solutions 

Focused on epigenetics, L’Oréal and Tru Diagnostic are building future-forward anti-aging beauty solutions. These products, grounded in longevity science, aim to enhance beauty from within and redefine how we care for skin and hair. 

Article source : https://www.loreal.com/en/press-release/research-and-innovation/strategic-research-partnership-with-tru-diagnostic/

On the same subject